These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9550372)

  • 1. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization.
    Mendoza RB; Cantwell MJ; Kipps TJ
    J Immunol; 1997 Dec; 159(12):5777-81. PubMed ID: 9550372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmids encoding granulocyte-macrophage colony-stimulating factor and CD154 enhance the immune response to genetic vaccines.
    Burger JA; Mendoza RB; Kipps TJ
    Vaccine; 2001 Feb; 19(15-16):2181-9. PubMed ID: 11228391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
    Shepherd DM; Kerkvliet NI
    J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.
    Nakajima A; Kodama T; Morimoto S; Azuma M; Takeda K; Oshima H; Yoshino S; Yagita H; Okumura K
    J Immunol; 1998 Aug; 161(4):1901-7. PubMed ID: 9712059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA.
    Leclerc C; Dériaud E; Rojas M; Whalen RG
    Cell Immunol; 1997 Aug; 179(2):97-106. PubMed ID: 9268493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation provided by DNA immunization enhances antitumor immunity.
    Corr M; Tighe H; Lee D; Dudler J; Trieu M; Brinson DC; Carson DA
    J Immunol; 1997 Nov; 159(10):4999-5004. PubMed ID: 9366427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes.
    Wu Y; Kipps TJ
    J Immunol; 1997 Dec; 159(12):6037-43. PubMed ID: 9550402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.
    Zelenay S; Elías F; Fló J
    Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA.
    Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M
    J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154.
    Mackey MF; Gunn JR; Ting PP; Kikutani H; Dranoff G; Noelle RJ; Barth RJ
    Cancer Res; 1997 Jul; 57(13):2569-74. PubMed ID: 9205055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination.
    Xu H; Zhao G; Huang X; Ding Z; Wang J; Wang X; Cheng Y; Kang Y; Wang B
    J Gene Med; 2010 Jan; 12(1):97-106. PubMed ID: 19950201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells.
    Peng X; Remacle JE; Kasran A; Huylebroeck D; Ceuppens JL
    J Immunol; 1998 Feb; 160(3):1166-72. PubMed ID: 9570530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization.
    Ross HM; Weber LW; Wang S; Piskun G; Dyall R; Song P; Takechi Y; Nikolić-Zugić J; Houghton AN; Lewis JJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2191-6. PubMed ID: 9815614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of both cellular and humoral responses to genetic immunization by co-administration of an antigen-expressing plasmid and a plasmid encoding the pro-apoptotic protein Bax.
    Kinsey BM; Marcelli M; Song L; Bhogal BS; Ittmann M; Orson FM
    J Gene Med; 2004 Apr; 6(4):445-54. PubMed ID: 15079819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
    Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
    Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.